686 top medical experts on Orchiectomy across 49 countries and 37 U.S. states, including 613 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Orchiectomy: The surgical removal of one or both testicles.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Male Urologic Surgical Procedures (1,145), Castration (1,337).
- Synonyms: Male Castration, Orchidectomy
- Petrylak, Daniel P Medical OncologySmilow Cancer Center, Yale University, New Haven, Connecticut. Top HospitalMedical school: Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University (MD, 1985)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100Disclosed payments in 2021 from 96 biomedical companies, totalling $90,146.67, including $20,761.43 from Astellas Pharma Global DevelopmentSubjects: Prostatic Neoplasms; Androgen Antagonists; Prostatic Neoplasms, Castration-Resistant; Tissue Extracts; Antineoplastic AgentsCategories: Therapeutic Use; Immunology; Therapy; Blood; Drug Therapy; Pathology
- Keating, Nancy L Internal MedicineHarvard Medical School and Brigham and Womens Hospital, Boston, MA, USA. Top HospitalSubjects: Prostatic Neoplasms; Antineoplastic Agents, Hormonal; Androgen Antagonists; Bile Duct Diseases; Gonadotropin-Releasing HormoneCategories: Adverse Effects; Epidemiology; Therapy; Etiology; Therapeutic Use; Agonists
- Scher, Howard I Medical OncologyDepartment of Medicine, Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York; Department of Medicine, Weill Cornell Medical College, New York.Disclosed payments in 2021 from 5 biomedical companies, totalling $10,310.5, including $8,380 from PFIZER INC.Subjects: Prostatic Neoplasms; Biomarkers, Tumor; Bone Neoplasms; Neoplasm Proteins; AndrogensCategories: Blood; Metabolism; Therapeutic Use; Genetics; Mortality; Immunology
- Fung, Chunkit Hematology & OncologyJames P Wilmot Cancer Institute, School of Medicine and Dentistry, University of Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA.PhysicianMedical school: Perelman School of Med at the University of Pennsylvania (MD, 2004)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100Disclosed payments from biomedical company (E.R. Squibb & Sons, L.L.C.) in 2021 for $18.91Subjects: Antineoplastic Agents; Cardiovascular Diseases; Neoplasms, Germ Cell and Embryonal; Prostatic Neoplasms; Testicular NeoplasmsCategories: Therapy; Adverse Effects; Mortality; Methods; Pathology; Therapeutic Use
- Hanna, Nasser H Hematology & OncologyDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN.Physician Highly CitedSubjects: Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy; RadiotherapyCategories: Methods; Therapy; Diagnosis; Surgery; Therapeutic Use
- Tagawa, Scott T Hematology & OncologyDepartment of Medicine, Weill Cornell Medical College, Weill Cornell Cancer Center, New York, NY 10065, USA.Physician Highly PublishedMedical school: University of Southern California Keck School of Medicine (MD, 1998)Medicare AcceptedDisclosed payments in 2021 from 21 biomedical companies, totalling $36,460.33, including $8,424.44 from PFIZER INC.Subjects: Prostatic Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Taxoids; Mass ScreeningCategories: Therapeutic Use; Administration & Dosage; Drug Therapy; Secondary; Therapy
- Gilbert, Scott M UrologyDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.PhysicianMedical school: Columbia University College of Physicians and Surgeons (MD, 2000)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 81/100Subjects: Prostatic Neoplasms; Seminoma; Testicular Neoplasms; Androgen Antagonists; Gonadotropin-Releasing HormoneCategories: Drug Therapy; Statistics & Numerical Data; Surgery; Agonists; Methods; Therapeutic Use
- Sharifi, Nima Hematology & OncologyDivision of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Top HospitalPhysician Highly PublishedDisclosed payments in 2021 from 2 biomedical companies, totalling $1,887.5, including $1,262.5 from Janssen Scientific Affairs, LLCSubjects: Prostatic Neoplasms; Androgen Antagonists; Androgens; Neoplasms, Hormone-Dependent; Antineoplastic Agents, HormonalCategories: Metabolism; Therapeutic Use; Drug Therapy; Genetics; Physiology; Adverse Effects
- Einhorn, Lawrence H Hematology & OncologyMelvin and Bren Simon Comprehensive Cancer Center, Indiana University,Indianapolis, Indiana.Subjects: Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease ManagementCategories: Methods; Surgery; Therapy; Diagnosis; Epidemiology; Pathology
- Nguyen, Paul L Radiation OncologyDepartment of Radiation Oncology, Brigham and Womens Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Top HospitalPhysician Highly PublishedDisclosed payments in 2021 from 34 biomedical companies, totalling $90,456.51, including $43,457.46 from Boston Scientific CorporationSubjects: Prostatic Neoplasms; Androgen Antagonists; Antineoplastic Agents, Hormonal; Myocardial Infarction; StrokeCategories: Adverse Effects; Epidemiology; Therapeutic Use; Therapy; Drug Therapy; Etiology
- Carducci, Michael A Medical OncologyDepartment of Oncology, Prostate Cancer and Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore.Subjects: Prostatic Neoplasms; Taxoids; Antineoplastic Agents; Ketoconazole; AndrostadienesCategories: Therapeutic Use; Drug Therapy; Immunology; Pharmacokinetics; Surgery; Therapy
- Shahinian, Vahakn B NephrologyDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-2029, USA.PhysicianMedical school: Other (MD, 1994)Medicare AcceptedSubjects: Prostatic Neoplasms; Androgen Antagonists; Antineoplastic Agents; Gonadotropin-Releasing Hormone; Health Services MisuseCategories: Statistics & Numerical Data; Therapeutic Use; Therapy; Agonists; Diagnosis; Drug Therapy
- Eisenberger, Mario A Medical OncologyDepartment of Oncology, Prostate Cancer and Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore.Disclosed payments in 2021 from 21 biomedical companies, totalling $30,530, including $22,750 from Merck Sharp & Dohme CorporationSubjects: Prostatic Neoplasms; Ketoconazole; Taxoids; Androstadienes; Antibodies, MonoclonalCategories: Therapeutic Use; Blood; Drug Therapy; Immunology; Surgery; Therapy
- Logothetis, Christopher J Medical OncologyThe University of Texas MD Anderson Cancer Center, Houston, TX.Physician Clinical TrialDisclosed payments in 2021 from 3 biomedical companies, totalling $6,765, including $6,765 from PFIZER INC.Subjects: Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Prostatic Neoplasms; Seminoma; AdenocarcinomaCategories: Physiology; Administration & Dosage; Diagnosis; Metabolism; Pathology; Surgery
- Galsky, Matthew D Medical OncologyThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Top HospitalMedical school: Tufts University School of Medicine (MD, 1998)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.4/100Disclosed payments in 2021 from 42 biomedical companies, totalling $79,966.11, including $17,087.5 from E.R. Squibb & Sons, L.L.C.Subjects: Prostatic Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Adenocarcinoma; Androgen Antagonists; Androgen Receptor AntagonistsCategories: Therapeutic Use; Drug Therapy; Drug Effects; Administration & Dosage; Adverse Effects; Blood
- Baker, Linda A Pediatric UrologyDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Division of Pediatric Urology, Childrens Health, Dallas, TX. Electronic address: . Top HospitalPhysician Highly CitedMedical school: University of Louisville School of Medicine (MD, 1989)Medicare AcceptedSubjects: Spermatic Cord Torsion; Orchiopexy; Pain; Pediatrics; TestisCategories: Surgery; Trends; Statistics & Numerical Data; Adverse Effects; Etiology; Pathology
- Cost, Nicholas G Pediatric UrologyDivision of Pediatric Urology, Childrens Hospital Colorado and Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: .Disclosed payments in 2021 from 2 biomedical companies, totalling $1,674.39, including $1,500 from Merck Sharp & Dohme CorporationSubjects: Testicular Neoplasms; Leydig Cell Tumor; Orchiopexy; Organ Sparing Treatments; Puberty, PrecociousCategories: Surgery; Methods; Pathology; Statistics & Numerical Data; Therapy; Secondary
- Higano, Celestia S Hematology & OncologyDivision of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. Top HospitalPhysician Clinical TrialDisclosed payments in 2021 from 26 biomedical companies, totalling $29,059.89, including $13,340 from PFIZER INC.Subjects: Prostatic Neoplasms; Androgen Antagonists; Prostatic Neoplasms, Castration-Resistant; Antineoplastic Agents; Bone and BonesCategories: Pathology; Pharmacology; Therapeutic Use; Administration & Dosage; Drug Effects; Drug Therapy
- Kibel, Adam S UrologyDivision of Urologic Surgery and Center for Surgery and Public Health, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, USA. Top HospitalPhysician Highly PublishedDisclosed payments in 2021 from 12 biomedical companies, totalling $14,868.08, including $5,125 from E.R. Squibb & Sons, L.L.C.Subjects: Prostatic Neoplasms; Androgen Antagonists; Antineoplastic Agents, Hormonal; Postoperative Complications; Gonadotropin-Releasing HormoneCategories: Adverse Effects; Etiology; Surgery; Therapy; Epidemiology; Therapeutic Use
- Ryan, Charles J Medical OncologyDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Top HospitalPhysicianDisclosed payments in 2021 from 4 biomedical companies, totalling $35,729.58, including $33,093 from Eli Lilly and CompanySubjects: Androgen Antagonists; Prostatic Neoplasms; Androstenols; Ethnicity; Practice Patterns, PhysiciansCategories: Statistics & Numerical Data; Therapeutic Use; Drug Therapy
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.